Business
Shoulder Innovations Announces Full Commercial Launch of the InSet™ 70 Humeral Stem
Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem ("InSet™ 70"). The introduction of the InSet™ 70 represents an expansion of the company's I-Series humeral stem product line, which first launched with the InSet™ 95 humeral stem in 2024.
About this update from Shoulder Innovations, Inc.
[{"type":"text","content":"Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio","length":110,"tagName":"p","attribs":{}},{"type":"text","content":"GRAND RAPIDS, Mich., Sept. 22, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem ("InSet™ 70"). The introduction of the InSet™ 70 represents an expansion of the company's I-Series humeral stem product line, which first launched with the InSet™ 95 humeral stem in 2024.","length":526,"tagName":"p"},{"type":"image","alt":"Shoulder Innovations company logo (PRNewsfoto/Shoulder Innovations)","displaySize":"","headline":null,"caption":"Shoulder Innovations company logo (PRNewsfoto/Shoulder Innovations)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":107,"url":"https://media.zenfs.com/en/prnewswire.com/8a1402851f2d0708bf3061fb1fe462a9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/H4DOYuDC98tSEIpdL7hYDA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE4OTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/8a1402851f2d0708bf3061fb1fe462a9","width":400,"height":107}},"href":"https://mma.prnewswire.com/media/779412/Shoulder_Innovations_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""The InSet™ 70 complements our broad portfolio of advanced shoulder implant solutions, and we are excited to bring it to market across the United States ahead of schedule," said Rob Ball, CEO of Shoulder Innovations. "SI has a strong history of innovation, and the InSet™ 70 is another example of new technology designed to enhance the quality of care for patients and provide meaningful value to the surgeons who care for them. We look forward to seeing improved patient outcomes and long-term function with this implant."","length":543,"tagName":"p"},{"type":"text","content":"Indicated for use in both anatomic and reverse shoulder arthroplasty, the InSet™ 70 addresses a broad range of clinical needs, including non-inflammatory degenerative joint disease such as osteoarthritis and avascular necrosis, rheumatoid and traumatic arthritis, and correction of func...